Matches in SemOpenAlex for { <https://semopenalex.org/work/W2243305826> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2243305826 endingPage "3142" @default.
- W2243305826 startingPage "3142" @default.
- W2243305826 abstract "3142 Background: The most common serious adverse event associated with thalidomide use for cancer patients has been DVT/PE. Methods: The Research on Adverse Drug Reactions and Reports (RADAR) project reviewed: 1) all DVT/PE cases reported to the FDA from 1998 to 2003 (n= 235 cases) and 2) medical literature reports for 2002–2003 (n= 22 studies) for incidence rates. Results: Case Report Information: In comparison with reports from clinical practice settings (n=166), clinical trial reports (n = 69) had higher rates of inclusion of information on: thalidomide administration dates (77% vs. 32%), DVT/PE onset date (62% vs. 23%), number of days from thalidomide administration to DVT/PE (52% vs. 17%), and DVT/PE treatment (76% vs. 42%) [p < .0001 for each comparison]. Both clinical trial and none clinical trial FDA adverse event reports were: 1) very complete for: patient age, gender, thalidomide dose, indication, and survival and 2) incomplete for information on tests used to document DVT/PE diagnoses and notation that the case had been reported to the System for Thalidomide Education and Prescribing Safety (STEPS) program. Incidence Rates varied according to cancer diagnosis, stage, and concomitant therapies: Conclusions: 1) Reporting of information on thalidomide-associated DVT/PE to the FDA or to STEPS is rarely complete, especially outside of the clinical trial setting and 2) rates of DVT/PE continue to be high, despite increased awareness of this complication. No significant financial relationships to disclose." @default.
- W2243305826 created "2016-06-24" @default.
- W2243305826 creator A5001124933 @default.
- W2243305826 creator A5005256466 @default.
- W2243305826 creator A5007773813 @default.
- W2243305826 creator A5016803459 @default.
- W2243305826 creator A5037145725 @default.
- W2243305826 creator A5057863127 @default.
- W2243305826 creator A5068686468 @default.
- W2243305826 creator A5071586004 @default.
- W2243305826 creator A5082834438 @default.
- W2243305826 creator A5085727850 @default.
- W2243305826 date "2004-07-15" @default.
- W2243305826 modified "2023-09-25" @default.
- W2243305826 title "Understanding thalidomide-associated deep vein thrombosis/pulmonary emboli (DVT/PE): Comparison of quality and information included in adverse event reports from clinical trials, clinical practice, STEPS, and the medical literature" @default.
- W2243305826 doi "https://doi.org/10.1200/jco.2004.22.90140.3142" @default.
- W2243305826 hasPublicationYear "2004" @default.
- W2243305826 type Work @default.
- W2243305826 sameAs 2243305826 @default.
- W2243305826 citedByCount "0" @default.
- W2243305826 crossrefType "journal-article" @default.
- W2243305826 hasAuthorship W2243305826A5001124933 @default.
- W2243305826 hasAuthorship W2243305826A5005256466 @default.
- W2243305826 hasAuthorship W2243305826A5007773813 @default.
- W2243305826 hasAuthorship W2243305826A5016803459 @default.
- W2243305826 hasAuthorship W2243305826A5037145725 @default.
- W2243305826 hasAuthorship W2243305826A5057863127 @default.
- W2243305826 hasAuthorship W2243305826A5068686468 @default.
- W2243305826 hasAuthorship W2243305826A5071586004 @default.
- W2243305826 hasAuthorship W2243305826A5082834438 @default.
- W2243305826 hasAuthorship W2243305826A5085727850 @default.
- W2243305826 hasConcept C126322002 @default.
- W2243305826 hasConcept C141071460 @default.
- W2243305826 hasConcept C177713679 @default.
- W2243305826 hasConcept C1862650 @default.
- W2243305826 hasConcept C197934379 @default.
- W2243305826 hasConcept C2776265017 @default.
- W2243305826 hasConcept C2776364478 @default.
- W2243305826 hasConcept C2778959117 @default.
- W2243305826 hasConcept C2779609412 @default.
- W2243305826 hasConcept C2779974597 @default.
- W2243305826 hasConcept C2780868729 @default.
- W2243305826 hasConcept C535046627 @default.
- W2243305826 hasConcept C71924100 @default.
- W2243305826 hasConceptScore W2243305826C126322002 @default.
- W2243305826 hasConceptScore W2243305826C141071460 @default.
- W2243305826 hasConceptScore W2243305826C177713679 @default.
- W2243305826 hasConceptScore W2243305826C1862650 @default.
- W2243305826 hasConceptScore W2243305826C197934379 @default.
- W2243305826 hasConceptScore W2243305826C2776265017 @default.
- W2243305826 hasConceptScore W2243305826C2776364478 @default.
- W2243305826 hasConceptScore W2243305826C2778959117 @default.
- W2243305826 hasConceptScore W2243305826C2779609412 @default.
- W2243305826 hasConceptScore W2243305826C2779974597 @default.
- W2243305826 hasConceptScore W2243305826C2780868729 @default.
- W2243305826 hasConceptScore W2243305826C535046627 @default.
- W2243305826 hasConceptScore W2243305826C71924100 @default.
- W2243305826 hasIssue "14_suppl" @default.
- W2243305826 hasLocation W22433058261 @default.
- W2243305826 hasOpenAccess W2243305826 @default.
- W2243305826 hasPrimaryLocation W22433058261 @default.
- W2243305826 hasRelatedWork W1970383787 @default.
- W2243305826 hasRelatedWork W1977732319 @default.
- W2243305826 hasRelatedWork W2094977200 @default.
- W2243305826 hasRelatedWork W2367237076 @default.
- W2243305826 hasRelatedWork W2414083368 @default.
- W2243305826 hasRelatedWork W2463643367 @default.
- W2243305826 hasRelatedWork W2753486433 @default.
- W2243305826 hasRelatedWork W2981563669 @default.
- W2243305826 hasRelatedWork W3022042949 @default.
- W2243305826 hasRelatedWork W1603374058 @default.
- W2243305826 hasVolume "22" @default.
- W2243305826 isParatext "false" @default.
- W2243305826 isRetracted "false" @default.
- W2243305826 magId "2243305826" @default.
- W2243305826 workType "article" @default.